LC-MS systems for quantitative bioanalysis

Bioanalysis

Volumn 4, Issue 19, 2012, Pages 2391-2399

  Van Dongen, William D ^a   Niessen, Wilfried M A ^b,c  

^a TNO   (Netherlands)

^b Hyphen MassSpec   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; DRUG METABOLITE; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; PEPTIDE;

ANALYSIS; ASSAY; BIOANALYSIS; LIGAND BINDING ASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; MOLECULE; QUADRUPOLE MASS SPECTROMETRY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; PROTEINS;

EID: 84867963752     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.221     Document Type: Review

References (37)

1. Hopfgartner G, Bourgogne E. Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry. Mass Spectrom. Rev. 22, 195-214 (2003).
2. Xu RN, Fan L, Rieser MJ, El-Shourbagy TA. Recent advances in high-throughput quantitative bioanalysis by LCYMS/MS. J. Pharm. Biomed. Anal. 44, 342-355 (2007).
3. Jemal M, Ouyang Z, Xia Y-Q. Systematic LCYMS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed. Chromatogr. 24, 2-19 (2010).
4. Viswanathan CT, Bansal S, Booth B et al. Workshop/conference report Y quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand-binding assays. AAPS J. 9(1) E30YE42 (2007).
5. Bronsema KJ, Bischoff R, Van de Merbel NC. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry. J. Chromatogr. B 893-894, 1-14 (2012).
6. Xia Y, Lau J, Olah T, Jemal M. Targeted quantitative bioanalysis in plasma using liquid chromatographyYhigh-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes. Rapid Commun. Mass Spectrom. 25, 2863-2878 (2011).
7. Fung EN, Xia Y-G, Aubry A-F, Zeng J, Olah T, Jemal J. Full-scan high resolution accurate mass spectrometry (HRMS) in regulated bioanalysis: LCYHRMS for the quantitation of prednisone and prednisolone in human plasma. J. Chromatogr. B 879, 2919-2927 (2011).
8. Heudi O, Barteau S, Zimmer D et al. Towards absolute quantification of therapeutic monoclonal antibody in serum by LCYMS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. Anal. Chem. 80, 4200-4207 (2008).
9. Van Dongen WD, Niessen WMA. Bioanalytical LCYMS of therapeutic oligonucleotides. Bioanalysis 3, 541-546 (2011).
10. Lesur A, Varesio E, Hopfgartner G. Accelerated tryptic digestion for the analysis of biopharmaceutical monoclonal antibodies in plasma by liquid chromatography with tandem mass spectrometric detection. J. Chromatogr. A 121(7), 57-64 (2010).
11. Wu ST, Ouyang Z, Olah TV, Jemal M. A strategy for liquid chromatographyYtandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection. Rapid Commun. Mass Spectrom. 25, 281-290 (2011).
12. Ouyang Z, Furlong MT, Wu S et al. Pellet digestion: a simple and efficient sample preparation technique for LCYMS/MS quantification of large therapeutic proteins in plasma. Bioanalysis 4(1), 17-28 (2012).
13. Ciccimaro E, Blair I. A stable-isotope dilution LCYMS for quantitative biomarker analysis. Bioanalysis 2, 311-341 (2010).
14. Ewles E, Goodwin L. Bioanalytical approaches to analyzing peptides and proteins by LCYMS/MS. Bioanalysis 3, 1379-1397 (2011).
15. Furlong MT, Ouyang Z, Wu Z et al. A universal surrogate peptide to enable LCYMS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in preclinical animal studies. Biomed. Chromatogr. 26(8), 1024-1032 (2012).
16. Li H, Ortiz R, Tran L et al. General LCYMS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies. Anal. Chem. 84, 1267-1273 (2012).
17. Becker GW. Stable isotopic labeling of proteins for quantitative proteomic applications. Briefing Funct. Gen. Proteom. 7, 371-382 (2008).
18. Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labelling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386 (2002).
19. Brun V. Isotope-labeled protein standards. Mol. Cell. Proteomics 6, 2139-2149 (2007).
20. Aguiar M. Mass spectrometric quantitation of C-reactive protein using labeled tryptic peptides. Anal. Biochem. 354, 175-181 (2006).
21. Addona TA, Abbatiello SE, Schilling B et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoringYbased measurements of proteins in plasma. Nat. Biotechnol. 27, 633-641 (2009).
22. Nirogi RVS, Kandikere VN. Shukla M, Mudigonda K, Maurya S, Boosi R. Quantification of clopidogrel in human plasma by sensitive liquid chromatography/ tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20, 1695-1700 (2006).
23. Čápka V, Carter SJ. Minimizing matrix effects in the development of a method for the determination of salmeterol in human plasma by LC/MS/MS at low pg/ml concentration levels. J. Chromatogr. B 856, 285-293 (2007).
24. Abrar M, Allanson J, Dalton P, Smith I, Young H. Development of a fg/ml level LCY MS/MS method for fluticasone propionate in human plasma. Presented at: EBF Open Meeting. Barcelona, Spain, 16-18 November 2011.
25. Xu X, Veals J, Korfmacher WA. Comparison of conventional and enhanced mass resolution triple-quadrupole mass spectrometers for discovery bioanalytical applications. Rapid Commun. Mass Spectrom. 17, 832-837 (2003).
26. Jemal M, Ouyang Z. Enhanced resolution triple-quadrupole mass spectrometry for fast quantitative bioanalysis using liquid chromatography/ tandem mass spectrometry: investigation of parameters that affect ruggedness. Rapid Commun. Mass Spectrom. 17, 24-38 (2003).
27. Kellmann M, Muenster HP, Zomer P, Mol H. Full-scan accurate mass selectivity of ultra-performance liquid chromatography combined with time-of-flight and orbitrap mass spectrometry in hormone and veterinary drug residue analysis. J. Am. Soc. Mass Spectrom. 20, 1464-1476 (2009).
28. Van der Heeft E, Bolck YJC, Beumer B, Nijrolder AWJM, Stolker AAM, Nielen MWF. Full-scan accurate mass selectivity of ultra-performance liquid chromatography combined with time-of-flight and orbitrap mass spectrometry in hormone and veterinary drug residue analysis. J. Am. Soc. Mass Spectrom. 20, 451-463 (2009).
29. Bateman KP, Kellmann M, Muenster H, Papp R, Taylor L. QuantitativeYqualitative data acquisition using a benchtop orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20, 1441-1450 (2009).
30. Henry H, Sobhi HR, Scheibner O, Bromirski M, Nimkar SB, Rochat B. Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs. Rapid Commun. Mass Spectrom. 26, 499-509 (2012).
31. Williamson L, Zhang G, Terry A, Bartlett M. Comparison of time-of-flight mass spectrometry to triple quadrupole tandem mass spectrometry for quantitative bioanalysis: application to antipsychotics. J. Liq. Chromatogr. Relat. Technol. 31, 2737-2751 (2008).
32. Ramanathan R, Jemal M, Ramagiri S et al. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS. J. Mass Spectrom. 46, 595-601 (2011).
33. Peters RJB, Stolker AAM, Mol JGJ et al. Screening in veterinary drug analysis and sports doping control based on full-scan, accurate-mass spectrometry. TRAC 29(11), 1250-1268 (2010).
34. Campbell JL, Le Blanc JCY. Using high-resolution quadrupole TOF technology in DMPK analysis. Bioanalysis 4, 487-500 (2012).
35. Mulvana DE. Critical topics in ensuring data quality in bioanalytical LCYMS development. Bioanalysis 2, 1051-1072 (2010).
36. Van den Broek I, Sparidans RW, Schellens JHM, Beijnen JH. Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry. J. Chromatogr. B 872, 1-22 (2008).
37. US FDA. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2001).